These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26089903)

  • 21. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity.
    Kopeikina LT; Kamper EF; Koutsoukos V; Bassiakos Y; Stavridis I
    Clin Rheumatol; 1997 May; 16(3):254-60. PubMed ID: 9184262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
    Wu WD; Xu YH; Tan PY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug; 15(8):472-5. PubMed ID: 12919647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and insertion/deletion polymorphism of the tissue-type plasminogen activator gene in atherothrombotic stroke.
    Bang CO; Park HK; Ahn MY; Shin HK; Hwang KY; Hong SY
    Cerebrovasc Dis; 2001; 11(4):294-9. PubMed ID: 11385207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships of blood pressure to fibrinolysis: influence of anthropometry, metabolic profile and behavioural variables.
    Cigolini M; Targher G; Seidell JC; Tonoli M; Schiavon R; Agostino G; De Sandre G
    J Hypertens; 1995 Jun; 13(6):659-66. PubMed ID: 7594424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
    Gürlek A; Bayraktar M; Kirazli S
    Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolytic activity in multiple myeloma.
    Yağci M; Sucak GT; Haznedar R
    Am J Hematol; 2003 Dec; 74(4):231-7. PubMed ID: 14635202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired fibrinolysis and insulin resistance in patients with hypertension.
    Jeng JR; Sheu WH; Jeng CY; Huang SH; Shieh SM
    Am J Hypertens; 1996 May; 9(5):484-90. PubMed ID: 8735180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationships between insulin and plasminogen activator inhibitor 1 levels: assessment in groups of subjects with dyslipidaemia and hypertension.
    Akanji AO; Al-Shayji I
    Clin Chim Acta; 1998 Jun; 274(1):41-52. PubMed ID: 9681596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of plasminogen activator inhibitor-1 and fibrinogen levels in relation to incident type 2 diabetes.
    Festa A; Williams K; Tracy RP; Wagenknecht LE; Haffner SM
    Circulation; 2006 Apr; 113(14):1753-9. PubMed ID: 16585388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.
    Velthuis-te Wierik EJ; Meijer P; Kluft C; van den Berg H
    Metabolism; 1995 Dec; 44(12):1548-52. PubMed ID: 8786722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome.
    Ehrmann DA; Schneider DJ; Sobel BE; Cavaghan MK; Imperial J; Rosenfield RL; Polonsky KS
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2108-16. PubMed ID: 9215280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
    Yu Y; Suo L; Yu H; Wang C; Tang H
    Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuation by gemfibrozil of expression of plasminogen activator inhibitor type 1 induced by insulin and its precursors.
    Nordt TK; Kornas K; Peter K; Fujii S; Sobel BE; Kübler W; Bode C
    Circulation; 1997 Feb; 95(3):677-83. PubMed ID: 9024157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
    Røder ME; Schwartz RS; Prigeon RL; Kahn SE
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2275-80. PubMed ID: 10852463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication.
    Parry DJ; Grant PJ; Scott DJ
    Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of rosiglitazone treatment on the fibrinolytic system in patients with type 2 diabetes mellitus.
    Guldiken S; Turgut B; Demir M; Arikan E; Kara M; Vural O; Tugrul A; Fareed J
    Clin Appl Thromb Hemost; 2006 Jan; 12(1):55-60. PubMed ID: 16444435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of plasminogen activator inhibitor type-1 (PAI-1) by proinsulin and insulin in vivo.
    Nordt TK; Sawa H; Fujii S; Sobel BE
    Circulation; 1995 Feb; 91(3):764-70. PubMed ID: 7828304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.